Description
Research-grade PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist (primarily MC3R and MC4R) intended for controlled laboratory investigations of central melanocortin signaling pathways. For Research Use Only. Not for human use.

Reviews
There are no reviews yet.